49 PIC/S Inspectorates Test-Drive Data Integrity Guidance
• By Joanne S. Eglovitch
Generate a summary of this article
Listen to this article
Pharmaceutical Inspection Cooperation Scheme member inspectorates are trying out the most comprehensive manufacturing data integrity guidance yet developed. Issued amid a flurry of guidance from various authorities, it could play a key role in harmonizing regulatory approaches.
The PIC/S Committee, shown here meeting in Kiev, Ukraine, in 2012, has approved draft data integrity guidance for six-month trial implementation among member inspectorates. • Source: Photo courtesy of PIC/S. Reprinted with permission.
An organization of 49 of the world's foremost pharmaceutical inspectorates has launched a six-month trial implementation of a guideline that could set the standard globally for enforcing data integrity in pharmaceutical manufacturing.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.